Product features

  • Purified complete microbial genome
  • Any sequence can be amplified
  • Precise concentration in copies/µl
  • Full sequence available.
  • Non-infectious material with inactivation certificate.
  • Lyophilised presentation
  • Valid for any molecular testing platform.

> Sequencing data available to assist in probe and primer design:

Kit AMPLIRUN

PRODUCTS

AMPLIRUN® MONKEYPOX VIRUS DNA CONTROL

RUO
Purified DNA of Monkeypox virus to be used to control techniques based in nucleic acids amplification.
Reference MBC146-R
Concentración 10,000-20,000 copies/μl
Volume 100 µl

HOW IT WORKS

AMPLIRUN how to use vertical

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Low SJ, O’Neill MT, Fernando JA, Kerry WJ, Prestedge J, Wild N, et al. CRISPR-Cas-based diagnostics for point-of-care detection of sexually transmitted infections: a laboratory development and evaluation study. Lancet Microbe. 2026;S2666-5247(25)00217-4.